Peer-reviewed article
Cognitive and Motor Outcomes of Children With Prenatal Opioid Exposure
Su Lynn Yeoh, John Graeme Eastwood, Ian M. R. Wright, Rachael Lisa Morton, Edward C. Melhuish et al. ·
Summary
Written by AI, not yet AICS's view · claude-haiku-4-5-20251001This systematic review and meta-analysis examined how prenatal opioid exposure affects children's cognitive and motor development from infancy through adolescence. The analysis of 26 cohort studies found that children exposed to opioids before birth showed measurably lower cognitive and motor scores compared to unexposed children, particularly in early childhood. These developmental differences persisted through school age, though the effect was less certain in older children. The findings suggest prenatal opioid exposure is linked to longer-term neurodevelopmental challenges requiring ongoing support.
Key points
- Cognitive development was significantly lower in POE children at 0-2 years (d = -0.52) and 3-6 years (d = -0.38), but the difference was not significant at 7-18 years
- Motor development scores were significantly lower in children with POE across all tested ages up to 6 years (d = -0.49)
- Analysis included 1455 children with prenatal opioid exposure compared to 2982 unexposed controls for cognitive outcomes
- Whether the developmental differences are caused by prenatal opioid exposure itself or by other factors such as withdrawal treatment remains uncertain
- The association between POE and neurodevelopmental delay persists from 6 months through adolescence
Limitations
This meta-analysis aggregates cohort studies without randomised controls, so causality cannot be definitively established. The study cannot distinguish whether developmental delays result directly from prenatal opioid exposure or from confounding factors such as treatment for neonatal abstinence syndrome, maternal comorbidities, or postnatal environment.
Abstract
Importance: Prenatal opioid exposure (POE) is one of the fastest-growing global health problems, but its association with long-term neurologic and physical development remains unknown. Objective: To assess the association between POE and cognitive and motor development in children from age 6 months to 18 years. Data Sources: Key search terms included prenatal opioid exposure, neonatal abstinence syndrome, and neurocognitive development. Studies were searched using PubMed and Embase, with no publication date restriction, through August 20, 2018. Study Selection: Only published cohort studies comparing the results of age-appropriate standardized cognitive and/or motor tests between children with any POE (aged 0-18 years) with drug-free controls were included. Data that were not convertible to means and SDs were excluded. Data Extraction and Synthesis: This study was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) and Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines. Data were pooled using a random-effects model. Main Outcomes and Measures: Standardized mean difference of cognitive and motor tests between POE and nonexposed children. Results: Twenty-six peer-reviewed cohort studies were included. Cognitive outcomes were compared for a total of 1455 children with POE and 2982 nonexposed children across 3 age groups (mean [SE] age at cognitive testing was 13 [1.58] months for the toddler group; 4.5 [0.38] years for the preschool group; and 13 [2.36] years for the school-aged group). Motor outcomes were compared for 688 children with POE and 1500 nonexposed children up to age 6 years (mean [SD] age at motor testing, 2 [0.45] years). Standardized mean difference was lower in cognitive tests for children with POE at 0 to 2 years (d = -0.52; 95% CI, -0.74 to -0.31; P < .001) and 3 to 6 years (d = -0.38; 95% CI, -0.69 to -0.07; P < .001); the difference was not significant for those aged 7 to 18 years (d = -0.44; 95% CI, -1.16 to 0.28; P = .23). Motor scores were lower in children with POE (d = 0.49; 95% CI, 0.23-0.74; P < .001). Conclusions and Relevance: Prenatal opioid exposure appeared to be negatively associated with neurocognitive and physical development from age 6 months, and this association persisted until adolescence. The cause and association of this with POE or other factors (eg, withdrawal treatment) are uncertain but suggest that POE necessitates long-term support and intervention.
Findings the Hub has extracted
Each claim below is labelled by its type of design and links back to this report.
- Intervention
- Identification and monitoring of children with prenatal opioid exposure; long-term developmental support and intervention
- Population
- Children aged 0-18 years with prenatal opioid exposure compared to drug-free controls across 26 cohort studies
Key finding
Cognitive scores were significantly lower in POE children at 0-2 years (standardized mean difference d = -0.52, 95% CI -0.74 to -0.31) and 3-6 years (d = -0.38, 95% CI -0.69 to -0.07)